Chicago's HAI/AR Unit commits to continued detection and response to antibiotic-resistant infections in healthcare settings.

CDPH Healthcare Associated Infections / Antimicrobial Resistance (HAI/AR) Unit

The CDPH HAI/AR Unit conducts onsite investigations and provides technical assistance to Chicago healthcare facilities in order to mitigate gaps in infection prevention and control. The HAI/AR Unit leverages surveillance data for public health responses and trains healthcare staff across the continuum of care in core antimicrobial stewardship principles and appropriate antimicrobial use. The HAI/AR Unit commits to work with state, local, academic, and clinical partners to establish regional standards for infection control and antimicrobial stewardship best practices to reduce the emergence and spread of multi-drug resistant bacteria.

HAI/AR Unit Project Lead(s) Contact Information
Medical Directors Dr. Stephanie Black
Dr. Do Young Kim
Projects Administrator Shane Zelencik Phone: 312-746-6035
Healthcare Associated Infections (HAI) Coordinator Hira Adil Phone: 743-0410
Skilled Nursing Facilities and Assisted Living (SNFAL) Liz Shane Phone: 312-746-6122
Acute Care Hospital, Outpatient, and Other (ACHOO) Maria Campos-Bovee Phone 312-744-3269
Epidemiology and Data Management Kelly Walblay Phone: 312-744-3376
Antimicrobial Stewardship Star Cervantes Phone: 312-744-3376
Therapeutics and Testing Christy Zelinski Phone: 312-746-4023
Project Firstline Alison VanDine Phone: 312-742-6716


MDRO Reporting Criteria for Healthcare Facilities in Chicago 
CDPH routinely monitors multidrug-resistant organisms (MDROs), specifically CRE, C. auris, CP-CRPA and CP-CRAB. For a list of MDRO reporting requirements for healthcare facilities and laboratories, please see table below.
Multi-drug resistant organism (MDRO) Is this Reportable? Report to
Candida auris, clinical Yes INEDSS
Candida auris, screening Yes INEDSS
CP-CRE, KPC or unknown mechanism Yes XDRO
CP-CRPA with mechanism

Not mandated by the state but CDPH would like reported INEDSS
CRPA or CP-CRPA with no/unknown mechanism No N/A

†  If you do not have access to I-NEDSS please report via encrypted email to the MDRO Prevention Epidemiologist (kelly.walblay@cityofchicago.org) 
‡CP-CRAB is not reportable in Illinois, however, please report any clusters of CRAB or individual cases of CRAB with non-OXA mechanisms to CDPH either via INEDSS or email the MDRO Prevention Epidemiologist (kelly.walblay@cityofchicago.org)
**In certain instances, additional information may be requested via a case report form in order to collect epidemiologic data as part of the public health investigation and response. If a case report form is needed, CDPH will reach out.

HAI Reporting Criteria for Healthcare Facilites in Chicago
Certain healthcare-associated infections are required to be reported to the National Healthcare Safety Network (NHSN) by CMS
Acute care hospitals are required to report the following:
  • SSI
  • C. difficile 
  • MRSA Bacteremia (not required for long-term acute care hospitals)
More details on CMS reporting requirements can be found here.

XDRO Registry
Extensively drug-resistant organisms (XDROs) are a major public health problem because there are no effective drugs currently available to treat infections caused by these bacteria. Detection of these organisms is possible as well as stopping the spread through Admission Screening coupled with consistent Point Prevalence Surveys at Long Term Care and Skilled Nursing facilities. To standardize the monitoring and reporting of these infections among facilities in Illinois, the XDRO registry was created. For access to the XDRO registry, click here.

Infection Control Assessment and Response Tools

The Infection Prevention and Control Assessment and Response (ICAR) tools were developed to assist in assessing infection prevention practices and guide quality improvement activities (e.g., by addressing identified gaps). These tools may also be used by healthcare facilities to conduct internal quality improvement audits. Facilities can schedule an ICAR visit with CDPH, for more information contact the SNFAL project lead or the ACHOO project lead (see contact table in overview).

ICAR Section 1
Select one demographic form based on your individual healthcare setting:
ICAR Section 2
Below are various assessment modules that cover a variety of infection prevention practices. Modules can be selected based on facility-specific concerns:

Infection Control and Prevention

Isolation Guidelines
Transmission-based precautions are an important tier of basic infection control and are to be used in addition to standard precautions to prevent transmission of infectious agents:
Multi-Drug Resistant Organisms (MDROs) Guidelines
Indwelling Devices 
Environmental Cleaning
Seasonal Influenza Guidance
Hand Hygiene

Tools and Resources

HAN Notifications
  • The Chicago Health Alert Network (HAN) is CDPH's primary method of sharing information about urgent and emerging public health situations with Chicago healthcare facilities, clinicians, laboratories and partner agencies.
Project Firstline
  • Project Firstline is a CDC effort that aims to provide engaging, innovative, and effective infection control training for millions of frontline U.S. healthcare workers as well as members of the public health workforce.
Inter-facility Infection Prevention Transfer Form
  • The purpose of the form is to convey information about a patient’s isolation precautions and the reason for their implementation to the receiving facility. The sending facility should record current infection and colonization information. This form is not intended to be a comprehensive documentation of microbiologic history and does not replace a review of medical records and communication between care providers. Please fill out this form and send it with all patients being transferred between healthcare facilities, regardless of whether or not they require isolation.
Antibiotic Resistance Threats in the United States 2019
  • The CDC report includes the latest national death and infection estimates for 18 antimicrobial-resistant bacteria and fungi. The germs are listed in three categories-urgent, serious, and concerning-based on level of concern to human health.
COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022
  • The special report highlights the impact of COVID-19 on antimicrobial resistance in the U.S. the pandemic pushed healthcare facilities, health departments, and communities near their breaking points in 2020, making it very hard to maintain the progress in combating antimicrobial resistance.
Illinois Progress Report
  • The CDC provides data on reporting general acute care, long term acute care, inpatient rehabilitation facilities, and critical access hospitals by state through the National Healthcare Safety Network (NHSN).
HAI Pathogens and Antimicrobial Resistance Report
  • NHSN’s HAI Pathogens and Antimicrobial Resistance Report provides a national snapshot of common HAI pathogens in U.S. inpatient healthcare facilities and includes national benchmark values for antimicrobial resistance (AR) across 8 urgent and serious drug-resistant phenotypes

HAI Reporting

For questions related to Healthcare Associated Infection/Antibiotic Resistance, please contact the Chicago Department of Public Health:
Hira Adil
email: hira.adil@cityofchicago.org
Phone: 312-743-0410

Asset Publisher

Upcoming Events

View All

10/13/2023 at 1:00 pm - 2:00 pm cst

IDPH: Isolation, Cohorting, and Enhanced Barrier Precautions - Oct. 13, 2023

IDPH Webinar


10/27/2023 at 1:00 pm - 2:00 pm cst

IDPH: Construction in the LTCF - Oct. 27, 2023

IDPH Webinar


11/10/2023 at 1:00 pm - 2:00 pm cst

IDPH: Common Skin Infections and Infestations in LTC - Nov. 10, 2023

IDPH Webinar


12/01/2023 at 1:00 pm - 2:00 pm cst

IDPH: Top 10 IDPH Deficiencies and How to Prevent Them - Dec. 1, 2023

IDPH Webinar


PALASE  Collaborative

A 1:1 collaborative approach to support nursing homes and skilled nursing facilities with implementing a robust Antimicrobial Stewardship Program (ASP) by leveraging acute care hospital (ACH) antimicrobial stewardship (AS) expertise.istration

Jamie Jacob, PharmD, BCIDP
Antimicrobial Stewardship Program Coordinator, IDPH